Our latest press releases, media appearances and news commentary.
Mark is Chief Business and Strategy Officer at the Medicines Discovery Catapult.
The amount of capital invested alongside CVC into UK companies increased six-fold between 2010 and 2015.
Chris Molloy responds to the Government’s Industrial Strategy White Paper.
Statement from Medicines Discovery Catapult.
Watch our new video introducing the Catapult programme, its centres and crucial work.
See how we can help support you with your next drug discovery project.
Speak to us